These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34052817)

  • 1. Hypocretin/Orexin, Sleep and Alzheimer's Disease.
    Dauvilliers Y
    Front Neurol Neurosci; 2021; 45():139-149. PubMed ID: 34052817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid β and tau are involved in sleep disorder in Alzheimer's disease by orexin A and adenosine A(1) receptor.
    Liu Z; Wang F; Tang M; Zhao Y; Wang X
    Int J Mol Med; 2019 Jan; 43(1):435-442. PubMed ID: 30365112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond the sleep-amyloid interactions in Alzheimer's disease pathogenesis.
    Ning S; Jorfi M
    J Neurophysiol; 2019 Jul; 122(1):1-4. PubMed ID: 30864847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors.
    Wang C; Holtzman DM
    Neuropsychopharmacology; 2020 Jan; 45(1):104-120. PubMed ID: 31408876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep-Wake Disorders in Alzheimer's Disease: A Review.
    Sun YY; Wang Z; Zhou HY; Huang HC
    ACS Chem Neurosci; 2022 May; 13(10):1467-1478. PubMed ID: 35507669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease.
    Roh JH; Jiang H; Finn MB; Stewart FR; Mahan TE; Cirrito JR; Heda A; Snider BJ; Li M; Yanagisawa M; de Lecea L; Holtzman DM
    J Exp Med; 2014 Dec; 211(13):2487-96. PubMed ID: 25422493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glymphatic dysfunction and sleep disorders: indirect effects on Alzheimer's disease].
    Kashchenko SA; Eranova AA; Chuguy EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2024; 124(4):7-12. PubMed ID: 38676671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Emerging Relationship Between Interstitial Fluid-Cerebrospinal Fluid Exchange, Amyloid-β, and Sleep.
    Boespflug EL; Iliff JJ
    Biol Psychiatry; 2018 Feb; 83(4):328-336. PubMed ID: 29279202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Orexin and Alzheimer's Disease.
    Liguori C
    Curr Top Behav Neurosci; 2017; 33():305-322. PubMed ID: 28012089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment.
    Arias-Carrión O; Bradbury M
    CNS Neurol Disord Drug Targets; 2009 Aug; 8(4):232-4. PubMed ID: 19689304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of hypocretins/orexins in sleep disorders and narcolepsy.
    Brown RE
    Drug News Perspect; 2003 Mar; 16(2):75-9. PubMed ID: 12792667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease pathogenesis: The role of disturbed sleep in attenuated brain plasticity and neurodegenerative processes.
    Havekes R; Heckman PRA; Wams EJ; Stasiukonyte N; Meerlo P; Eisel ULM
    Cell Signal; 2019 Dec; 64():109420. PubMed ID: 31536750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle.
    Kang JE; Lim MM; Bateman RJ; Lee JJ; Smyth LP; Cirrito JR; Fujiki N; Nishino S; Holtzman DM
    Science; 2009 Nov; 326(5955):1005-7. PubMed ID: 19779148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sleep-wake regulation and the hallmarks of the pathogenesis of Alzheimer's disease.
    Van Egroo M; Narbutas J; Chylinski D; Villar González P; Maquet P; Salmon E; Bastin C; Collette F; Vandewalle G
    Sleep; 2019 Apr; 42(4):. PubMed ID: 30649520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypocretin/orexin system in health and disease.
    Nishino S
    Biol Psychiatry; 2003 Jul; 54(2):87-95. PubMed ID: 12873797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer's disease.
    Morrone CD; Raghuraman R; Hussaini SA; Yu WH
    Mol Neurodegener; 2023 Apr; 18(1):27. PubMed ID: 37085942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
    Gao F; Liu T; Tuo M; Chi S
    Neurosci Lett; 2021 Nov; 765():136247. PubMed ID: 34530113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease.
    Cedernaes J; Osorio RS; Varga AW; Kam K; Schiöth HB; Benedict C
    Sleep Med Rev; 2017 Feb; 31():102-111. PubMed ID: 26996255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurobiological underpinning of the circadian wake signal.
    Zeitzer JM
    Biochem Pharmacol; 2021 Sep; 191():114386. PubMed ID: 33359009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis.
    Treu SP; Plante DT
    Sleep Med; 2021 Sep; 85():230-238. PubMed ID: 34364094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.